“Building Strategic Partnerships Between IP Law Firms and Biopharma”

In an article published by Life Science Leader, Marshall Gerstein Partner and Chair of the Biotech & Life Sciences Practice Eric M. Brusca, Ph.D., shares insights on the essential elements that distinguish transactional legal services from truly external partnerships and explores how both biopharmaceutical companies and their IP law firms can cultivate relationships that drive meaningful business value.   

“The most effective partnerships between biopharmaceutical companies and IP law firms are built on a foundation that extends well beyond technical legal competence,” Eric writes. “While expertise in patent prosecution, portfolio management, and litigation remains table stakes, what differentiates exceptional outside counsel is their capacity to function as strategic advisors who understand the biopharmaceutical business at a fundamental level.”

Read Eric’s article with guidance on strategic collaboration in Life Science Leader.